Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany

Minerva Anestesiologica

Volumn 72, Issue 7-8, 2006, Pages 645-654

  Heringlake, M ^a   Knappe, M ^a   Vargas Hein, O ^b   Lufft, H ^c   Kindgen Milles, D ^d   Bottiger B W ^e   Weigand, M A ^e   Klaus, S ^a   Schirmer, U ^f  

^a UNIVERSITY OF LÜBECK   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF ULM   (Germany)

Author keywords

Acute dialysis quality initiative; Acute renal failure; Cardiovascular surgical procedures; Creatinine; Hemodynamics; Inotropic drugs; Renal replacement therapy; Vasoactive drugs

Indexed keywords

CREATININE; DOBUTAMINE; DOPAMINE; ENOXIMONE; HYPERTENSIVE FACTOR; INOTROPIC AGENT; LOOP DIURETIC AGENT; MILRINONE; NORADRENALIN;

ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; FLUID THERAPY; GERMANY; HEALTH SURVEY; HEART SURGERY; HUMAN; INCIDENCE; INJURY; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; OLIGURIA; PROSPECTIVE STUDY; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT;

CARDIAC SURGICAL PROCEDURES; CARDIOVASCULAR AGENTS; GERMANY; HUMANS; KIDNEY DISEASES; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 33747448627     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 1998;128:194-203.
2. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998;104:343-8.
3. Lassnigg A, Schmidlin D, Mouhieddine M, Bachmann LM, Druml W, Bauer P et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004;15:1597-605.
4. Loef BG, Epema AH, Smilde TD, Henning RH, Ebels T, Navis G et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 2005;16:195-200.
5. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
6. Durtschi AJ, Kellum J, Datsa JF, Kane SK, Hoffman S, Pathak D. Effect of acute renal failure severity using ADQI-RIFLE criteria on resource use and clinical outcomes following cardiac bypass surgery. J Am Soc Nephrol 2003;14:510.
7. Boldt J, Brenner T, Lehmann A, Suttner SW, Kumle B, Isgro F. Is kidney function altered by the duration of cardiopulmonary bypass? Ann Thorac Surg 2003;75: 906-12.
8. Fischer UM, Weissenberger WK, Warters RD, Geissler HJ, Allen SJ, Mehlhorn U. Impact of cardiopulmonary bypass management on postcardiac surgery renal function. Perfusion 2002;17:401-6.
9. Rosenthal MH. Intraoperative fluid management: what and how much? Chest 1999;115:106S-112S
10. Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995;130: 423-9.
11. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.
12. Tang AT, El-Gamel A, Keevil B, Yonan N, Deiraniya AK. The effect of 'renal-dose' dopamine on renal tubular function following cardiac surgery: assessed by measuring retinol binding protein (RBP). Eur J Cardiothorac Surg 1999;15:717-21.
13. Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest 2003;123:1266-75.
14. Argalious M, Motta P, Khandwala F, Samuel S, Koch CG, Gillinov AM et al. "Renal dose" dopamine is associated with the risk of new-onset atrial fibrillation after cardiac surgery. Crit Care Med 2005;33:1327-32.
15. Rubens FD, Mesana T. The inflammatory response to cardiopulmonary bypass: a therapeutic overview. Perfusion 2004;19:S5-S12.
16. Albanese J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest 2004;126:534-9.
17. Meier-Hellmann A, Reinhart K, Bredle DL, Specht M, Spiess CD, Hannemann L. Epinephrine impairs splanchnic perfusion in septic shock. Crit Care Med 1997;25:399-404.
18. Guerin JP, Levraut J, Samat-Long C, Leverve X, Grimaud D, Ichai C. Effects of dopamine and norepinephrine on systemic and hepatosplanchnic hemodynamics, oxygen exchange, and energy balance in vasoplegic septic patients. Shock 2005;23:18-24.
19. Jakob SM, Ruokonen E, Takala J. Effects of dopamine on systemic and regional blood flow and metabolism in septic and cardiac surgery patients. Shock 2002;18:8-13.
20. Epstein FH, Brezis M, Silva P, Rosen S. Physiological and clinical implications of medullary hypoxia. Artif Organs 1987;11:463-7.
21. Sward K, Valsson F, Sellgren J, Ricksten SE. Differential effects of human atrial natriuretic peptide and furosemide on glomerular filtration rate and renal oxygen consumption in humans. Intensive Care Med 2005;31:79-85.
22. Schoors DF, Dupont AG. Further studies on the mechanism of the natriuretic response to low-dose dopamine in man: effect on lithium clearance and nephrogenic cAMP formation. Eur J Clin Invest 1990;20:385-91.
23. Lassnigg A, Donner E, Grubhofer G, Presterl E, Druml W, Hiesmayr M. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery. J Am Soc Nephrol 2000;11:97-104.